Colony-stimulating factors in inflammation and autoimmunity

JA Hamilton - Nature Reviews Immunology, 2008 - nature.com
Although they were originally defined as haematopoietic-cell growth factors, colony-
stimulating factors (CSFs) have been shown to have additional functions by acting directly …

Hematopoietic cytokines

D Metcalf - Blood, The Journal of the American Society of …, 2008 - ashpublications.org
The production of hematopoietic cells is under the tight control of a group of hematopoietic
cytokines. Each cytokine has multiple actions mediated by receptors whose cytoplasmic …

Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer

J Crawford, H Ozer, R Stoller, D Johnson… - Clinical infectious …, 1994 - academic.oup.com
Background Neutropenia and infection are major dose-limiting side effects of chemotherapy.
Previous studies have suggested that recombinant methionyl granulocyte colony-stimulating …

Management of fever in patients with cancer and treatment-induced neutropenia

PA Pizzo - New England Journal of Medicine, 1993 - Mass Medical Soc
The importance of neutropenia in the risk of serious infection in patients with cancer who are
receiving cytotoxic chemotherapy was first recognized nearly 30 years ago1. Since then …

Chemotherapy-induced and/or radiation therapy-induced oral mucositis-complicating the treatment of cancer

MUR Naidu, GV Ramana, PU Rani, A Suman, P Roy - Neoplasia, 2004 - Elsevier
The term mucositis is coined to describe the adverse effects of radiation and chemotherapy
treatments. Mucositis is one of the most common adverse reactions encountered in radiation …

Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy

P Mauch, L Constine, J Greenberger, W Knospe… - International Journal of …, 1995 - Elsevier
The bone marrow is an important dose-limiting cell renewal tissue for chemotherapy, wide-
field irradiation, and autologous bone marrow transplantion. Over the past 5–10 years a …

An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas.

K Antman, J Crowley, SP Balcerzak… - Journal of clinical …, 1993 - ascopubs.org
PURPOSE AND METHODS Doxorubicin alone or with dacarbazine (DTIC; AD) is
considered the best available therapy for metastatic adult sarcomas. Ifosfamide is active in …

Averting inflammation by targeting the cytokine environment

M Kopf, MF Bachmann, BJ Marsland - Nature Reviews Drug Discovery, 2010 - nature.com
Cytokines are key instigators and regulators of immune responses and therefore hold great
potential as targets for new therapeutic strategies. However, the selection of which cytokines …

Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions

A Barasch, DE Peterson - Oral oncology, 2003 - Elsevier
A multitude of laboratory and clinical research studies of ulcerative oral mucositis induced by
cytotoxic cancer therapies have been reported during the past decade. However, a …

Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability

E Carballo, WS Lai… - Blood, The Journal of the …, 2000 - ashpublications.org
Deficiency of tristetraprolin (TTP), the prototype of the CCCH zinc finger proteins, results in a
complex inflammatory syndrome in mice. Most aspects of the syndrome are secondary to …